2-Bromo-4-(trifluoromethoxy)benzoic acid methyl ester, 97%, 5g

(S)-Ethyl 9,10-difluoro-3-methyl-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate, 95.0%, 100g

(R)-tert-Butyl 2-(1,3-dioxoisoindolin-2-yloxy)-4-methylpentanoate, 98%, 1g

Morpholin-4-ylacetic acid hydrochloride, 97.0%, 1g

(S)-4-Boc-(3-hydroxymethyl)morpholine, 97.0%, 5g

(R)-3-(tert-Butyl)-4-(2,6-diphenoxyphenyl)-2,3-dihydrobenzo[d][1,3]oxaphosphole, 97%, 100mg

5,6,7,8-Tetrahydro-1,8-naphthyridin-2-propylamine dihydrochloride, 95.0%, 250mg

trans,trans-4-Propyl-4'-(4-propoxy-2,3-difluorophenyl)bicyclohexyl>98.0%(GC)1g

3-Bromo-1H-pyrazolo[3,4-b]pyrazine, 95.0%, 250mg

Methyl 4-(3-Bromopropyl)benzoate, 95.0%, 1g

Ru-MACHO(regR) (contains 5% Toluene at maximum)1g

Ethyl 3-bromo-6-chloro-2-fluorobenzoate, 98%, 1g

4-Benzylpiperazine-2,6-dione, 95%, 1g